Phillip H. Gallimore
- Molecular Biology top 10%
- Genetics top 2%
- Oncology top 5%
- Epidemiology top 10%
- Immunology top 10%
- Co-authors
- Roger J.A. GrandAndrew S. TurnellSally RobertsLan Bo ChenJames K. McDougallK RaskaS M RookesJane C. Steele
- Topics
- Virus-based gene therapy research (46 papers)CAR-T cell therapy research (12 papers)RNA Interference and Gene Delivery (12 papers)
- Cited by
- GeneticsOncologyBiotechnology
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Phillip H. Gallimore
61 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 76
- Molecular Biology 1.1k
- Genetics 1.0k
- Oncology 579
- Epidemiology 303
- Immunology 264
Countries citing papers authored by Phillip H. Gallimore
This map shows the geographic impact of Phillip H. Gallimore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phillip H. Gallimore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phillip H. Gallimore more than expected).
Fields of papers citing papers by Phillip H. Gallimore
This network shows the impact of papers produced by Phillip H. Gallimore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phillip H. Gallimore. The network helps show where Phillip H. Gallimore may publish in the future.
Co-authorship network of co-authors of Phillip H. Gallimore
This figure shows the co-authorship network connecting the top 25 collaborators of Phillip H. Gallimore. A scholar is included among the top collaborators of Phillip H. Gallimore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phillip H. Gallimore. Phillip H. Gallimore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 11 | |
| 3 | 2 | |
| 4 | 82 | |
| 5 | 19 | |
| 6 | 29 | |
| 7 | 14 | |
| 8 | 6 | |
| 9 | 11 | |
| 10 | 12 | |
| 11 | 43 | |
| 12 | 8 | |
| 13 | 4 | |
| 14 | 5 | |
| 15 | 12 | |
| 16 | 55 | |
| 17 | 24 | |
| 18 | 7 | |
| 19 | 14 | |
| 20 | 17 |
About Phillip H. Gallimore
Phillip H. Gallimore is a scholar working on Genetics, Oncology and Biotechnology, having authored 61 papers that have together received 1.7k indexed citations. Recurring topics across this work include Virus-based gene therapy research (46 papers), CAR-T cell therapy research (12 papers) and RNA Interference and Gene Delivery (12 papers). The work is most often cited by research in Genetics (1.0k citations), Oncology (579 citations) and Biotechnology (173 citations). Phillip H. Gallimore has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Roger J.A. Grand, Andrew S. Turnell, Sally Roberts, Lan Bo Chen, James K. McDougall, K Raska, S M Rookes, Jane C. Steele, Philip J. Byrd and John Doorbar. Their work appears in journals such as Nature, Cell and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.